Free shipping on all orders over $ 500

NAZ2329

Cat. No. M25432

All AbMole products are for research use only, cannot be used for human consumption.

NAZ2329 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

NAZ2329 is the first cell-permeable inhibitor of R5 subfamily of receptor-type protein tyrosine phosphatases (RPTPs), allosterically and preferentially inhibits PTPRZ (IC50=7.5 µM for hPTPRZ1) and PTPRG (IC50=4.8 µM for hPTPRG) over other PTPs. NAZ2329 binds to the active D1 domain and more potently inhibits PTPRZ-D1 fragment (IC50 of 1.1 µM) than the whole intracellular (D1 + D2) fragment (IC50 of 7.5 µM).

NAZ2329 can effectively inhibit tumor growth of the glioblastoma cells. NAZ2329 (25 µM; 0-90 min) obviously promotes the phosphorylation level of paxillin at Tyr-118 site, leading to inhibition for PTPR substrate.

In vivo, NAZ2329 (22.5 mg/kg; intraperitoneal injection; twice per week; 40 days) has a moderate inhibitory effect.

Chemical Information
Molecular Weight 501.56
Formula C21H18F3NO4S3
CAS Number 2809469-05-2
Solubility (25°C) DMSO 80 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Clement Agoni, et al. RSC Adv. Allosteric inhibition induces an open WPD-loop: a new avenue towards glioblastoma therapy

[2] Akihiro Fujikawa, et al. J Biol Chem. A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z

[3] Akihiro Fujikawa, et al. Sci Rep. Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells

Related Phosphatase Products
RMC-3943 

RMC-3943 is an allosteric SHP2 inhibitor (inhibition of full-length SHP2 in biochemical assay, IC50 = 2.19 nM).

LYP-IN-1 

LYP-IN-1 is a potent, selective and specific LYP inhibitor with a Ki and an IC50 of 110 nM and 0.259 μM, respectively.

PF-07284892

PF-07284892 (ARRY-558) is a potent and orally active SHP2 inhibitor with an IC50 value of 21 nM.

MY10 

MY10 is a potent and orally active receptor protein tyrosine phosphatase (RPTPβ/ζ) inhibitor.

CPDA 

CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: NAZ2329 supplier, Phosphatase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.